These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29604264)
21. Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints. Macklin EA; Blacker D; Hyman BT; Betensky RA J Alzheimers Dis; 2013; 36(3):475-86. PubMed ID: 23629586 [TBL] [Abstract][Full Text] [Related]
22. [Registries to Boost the Clinical Trials for the Disease Modifying Therapy of Alzheimer's Disease]. Akiyama H Brain Nerve; 2017 Jul; 69(7):743-748. PubMed ID: 28739987 [TBL] [Abstract][Full Text] [Related]
23. Development of a Mobile-First Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies. Aggarwal R; Sidnam-Mauch E; Neffa-Creech D; Plant A; Williams E; Shami E; Menon U; George S; Langbaum JB J Prev Alzheimers Dis; 2023; 10(4):857-864. PubMed ID: 37874108 [TBL] [Abstract][Full Text] [Related]
24. Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes. Gregory S; Wells K; Forysth K; Latto C; Szyra H; Saunders S; Ritchie CW; Milne R Dementia (London); 2018 Nov; 17(8):1045-1054. PubMed ID: 30373458 [TBL] [Abstract][Full Text] [Related]
25. Editorial: Accelerating Preclinical Alzheimer's Clinical Trials through a Trial-Ready Cohort with Diverse Representation. Lee AKW; Correia S; Salloway SP J Prev Alzheimers Dis; 2020; 7(4):204-205. PubMed ID: 32920619 [No Abstract] [Full Text] [Related]
26. Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases. Larsen ME; Curry L; Mastellos N; Robb C; Car J; Middleton LT PLoS One; 2015; 10(11):e0141806. PubMed ID: 26599631 [TBL] [Abstract][Full Text] [Related]
27. Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives. Wang J; Tan L; Yu JT J Alzheimers Dis; 2016; 50(4):927-45. PubMed ID: 26836177 [TBL] [Abstract][Full Text] [Related]
28. Aging, Practice Effects, and Genetic Risk in the Wisconsin Registry for Alzheimer's Prevention. Jonaitis EM; Koscik RL; La Rue A; Johnson SC; Hermann BP; Sager MA Clin Neuropsychol; 2015; 29(4):426-41. PubMed ID: 26012360 [TBL] [Abstract][Full Text] [Related]
29. The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview. Aisen PS; Sperling RA; Cummings J; Donohue MC; Langford O; Jimenez-Maggiora GA; Rissman RA; Rafii MS; Walter S; Clanton T; Raman R J Prev Alzheimers Dis; 2020; 7(4):208-212. PubMed ID: 32920621 [TBL] [Abstract][Full Text] [Related]
30. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment? Cox CG; Ryan MM; Gillen DL; Grill JD J Prev Alzheimers Dis; 2021; 8(1):52-58. PubMed ID: 33336225 [TBL] [Abstract][Full Text] [Related]
31. Ethical Frameworks for Disclosure of Alzheimer Disease Biomarkers to Research Participants: Conflicting Norms and a Nuanced Policy. Bunnik EM; Smedinga M; Milne R; Georges J; Richard E; Schermer MHN Ethics Hum Res; 2022 Nov; 44(6):2-13. PubMed ID: 36316970 [TBL] [Abstract][Full Text] [Related]
32. The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Weiner MW; Nosheny R; Camacho M; Truran-Sacrey D; Mackin RS; Flenniken D; Ulbricht A; Insel P; Finley S; Fockler J; Veitch D Alzheimers Dement; 2018 Aug; 14(8):1063-1076. PubMed ID: 29754989 [TBL] [Abstract][Full Text] [Related]
35. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials. Grill JD; Zhou Y; Elashoff D; Karlawish J Neurobiol Aging; 2016 Mar; 39():147-53. PubMed ID: 26923411 [TBL] [Abstract][Full Text] [Related]
36. Clinical observational research on Alzheimer's disease: what clinical trial registries can tell. Dal-Ré R; Fauria K; Gramunt N; Molinuevo JL J Alzheimers Dis; 2013; 34(1):183-90. PubMed ID: 23186984 [TBL] [Abstract][Full Text] [Related]
37. Design of comprehensive Alzheimer's disease centers to address unmet national needs. Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979 [TBL] [Abstract][Full Text] [Related]
38. Disease Modelling of Cognitive Outcomes and Biomarkers in the European Prevention of Alzheimer's Dementia Longitudinal Cohort. Howlett J; Hill SM; Ritchie CW; Tom BDM Front Big Data; 2021; 4():676168. PubMed ID: 34490422 [TBL] [Abstract][Full Text] [Related]